⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer

Official Title: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Trial Investigating Two Doses of EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer (mCRPC)

Study ID: NCT01360840

Study Description

Brief Summary: The primary objective of the trial is to evaluate the clinical anti-tumor activity of EMD 525797 administered as 1-hour intravenous infusion every 3 weeks in terms of progression free survival (PFS) time in subjects with asymptomatic or mildly symptomatic metastatic castrate-resistant prostate cancer (mCRPC).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

Research Site, Pleasant Hill, California, United States

Research Site, Chicago, Illinois, United States

Research Site, New Orleans, Louisiana, United States

Research Site, Ann Arbor, Michigan, United States

Research Site, Detroit, Michigan, United States

Research Site, New Brunswick, New Jersey, United States

Research Site, Cleveland, Ohio, United States

Research Site, Dallas, Texas, United States

Research Site, Houston, Texas, United States

Research Site, Tyler, Texas, United States

Research Site, Roanoke, Virginia, United States

Research Site, Spokane, Washington, United States

Research Site, Bendigo, , Australia

Research Site, Coffs Harbour, , Australia

Research Site, Darlinghurst, , Australia

Research Site, Frankston, , Australia

Research Site, Gosford, , Australia

Research Site, Kurralta Park, , Australia

Research Site, Northmead, , Australia

Research Site, Port Macquarie, , Australia

Research Site, Randwick, , Australia

Research Site, Turnhout, , Australia

ZNA Middelheim Oncologie, Antwerp, , Belgium

Brandord Urology Research, Brantford, Ontario, Canada

Exdeo Clinical Research Inc., Abbotsford, , Canada

Can-Med Clinical Research Inc., Province of British Columbia, , Canada

Sunnybrook Health Sciences Centre, Toronto, , Canada

Research Site, Victoria, , Canada

Research Site, Windsor, , Canada

Research Site, Angers, , France

Center Alexis Vaurrin, Bourgogne, , France

Research Site, Caen Cedex 05, , France

Hôpitaux Civils de Colmar-CH Louis Pasteur, Colmar, , France

Research Site, Paris, , France

Research Site, Reims, , France

Institute Gustave Roussy, Villejuif, , France

Research Site, Aachen, , Germany

Universitätsmedizin Charité, Campus Benjamin Franklin, Urologische Klinik and Poliklinik, Berlin, , Germany

Research Site, Darmstadt, , Germany

Universitätsklinikum Carl Gustav Carus an der Techischen Universität Dresden, Klinik und Poliklinik für Urologie, Dresden, , Germany

Research Site, Esslingen, , Germany

Research Site, Freiburg, , Germany

Research Site, Hannover, , Germany

Research Site, Nürtingen, , Germany

Studienpraxis Urologie, Reutlingen, , Germany

Universitätsklinikum Tübinger, Klinik und Poliklinik für Urologie, Tübingen, , Germany

Research Site, Blaricum, , Netherlands

Research Site, Groningen, , Netherlands

Research Site, Haarlem, , Netherlands

Research Site, Gdańsk, , Poland

Research Site, Lublin, , Poland

Research Site, Łódź, , Poland

Altay Regional Oncology Dispensary, Barnaul, , Russian Federation

Research Site, Barnaul, , Russian Federation

Research Site, Ekaterinburg, , Russian Federation

State Institution of Healthcare Ivanovo Regional Oncology Dispensary, Ivanovo, , Russian Federation

Budzhet Clinical Oncology Center, Izhevsk, , Russian Federation

Research Site, Kazan, , Russian Federation

Krasnoyarsk State Medical University Oncology and Radiotherapy Territorial Dispensary, Krasnoyarsk, , Russian Federation

Research Site, Omsk, , Russian Federation

City Hospital # 2, Petersburg, , Russian Federation

Research Site, Stavropol, , Russian Federation

Research Site, Presov, , Slovakia

Research Site, Gauteng, , South Africa

Research Site, Kwa-Zulu Natal, , South Africa

Research Site, Pretoria Gauteng, , South Africa

Research Site, Western Cape, , South Africa

Research Site, Barcelone, , Spain

Research Site, Madrid, , Spain

Research Site, Pamplona, , Spain

Research Site, Sabadell, Barcelone, , Spain

Contact Details

Name: Medical Responsible

Affiliation: EMD Serono Inc., an affiliate of Merck KGaA, Darmstadt, Germany

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: